Dr. Vipin Valam Puthussery

• Started the department in Aster Medcity in October 2015
• Number of OPs seen per day – 35-40
• Number of IP consultations seen per day – 25-30
• Number of admissions – 1-3 /week
• Made Diabetic monitoring chart with insulin correction doses – for inpatients, for patients on enteral feeds
• Made insulin infusion protocols along with ICU team – for DKA, HSS, Hyperglycemia
• Made Diabetic Education material for Inpatients and out patients
• Conducted Aster Endo summit 2017, 2018, 2019 – with a grand success (along with Endo team)

Clinical Trials

• A Phase III Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-centre, Multinational Study to Evaluate Efficacy and Safety of TRC150094 as an Add on to Standard of Care in Improving Cardiovascular Risk in Subjects with Diabetes, Dyslipidemia and Hypertension – Co Investigator (On Going)
• A 26-week Randomized Open-label, Parallel group Comparison of SAR341402 Mix 70/30 to Novomix 30 in Adult Patients with Diabetes Mellitus using Pre-mixe Insulin Analogs – Principal investigator (On Going)
• An Indian multi-centre, prospective, open-label, single-arm, non-interventional, post marketing surveillance study of Fiasp® to evaluate safety and effectiveness in patients with diabetes mellitus in routine clinical practice- Study Number: NN1218-4489 – Principal Investigator (ongoing)

Other research Experience

Dissertation: “Prevalence of diabetic peripheral neuropathy in rural Trivandrum – a community-based study” for the degree of Doctor of Medicine, in General Medicine under University of Kerala.

1. “Cardiovascular disease risk assessment in parents of women with PCOS” for degree of Doctorate of Medicine in Endocrinology under SGPGIMS, Lucknow with Dr Preeti Dabadghao (Associate Professor, Endocrinology, SGPGIMS).
2. “Prevalence and clinical significance of ZnT8A in young North Indian Type 1 Diabetes mellitus patients” for degree of Doctorate of Medicine in Endocrinology under SGPGIMS, Lucknow with Dr Eesh Bhatia (Professor and Head, Endocrinology, SGPGIMS)

• ISPAD 2018 Poster – Low prevalence of Islet Antibody negative type 1 diabetes mellitus among children and adolescents in north India.
• ESICON 2015, Chandigarh – Oral presentation – “Frequency of ZnT8A in Indian type 1 diabetes patients”
• ESICON 2015, Chandigarh – Poster presentation – ‘Cardiovascular disease risk assessment in parents of PCOS patients”

1. Fertil Steril. 2016 May;105(5):1338-1344.e3. doi: 10.1016/j.fertnstert.2016.01.024. Epub 2016 Feb 4. Cardiovascular disease risk in first-degree relatives of women with polycystic ovary syndrome. Vipin VP1, Dabadghao P2, Shukla M1, Kapoor A3, Raghuvanshi AS3, Ramesh V4. www.ncbi.nlm.nih.gov/pubmed/26852421
2. Hum Reprod. 2019 Jul 12. pii: dez104. doi: 10.1093/humrep/dez104. [Epub ahead of print] Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome. Karthik S1, Vipin VP2, Kapoor A3, Tripathi A4, Shukla M4, Dabadghao P4.
3. Indian J Med Res 149, April 2019, pp 479-488 Heterogeneity in the aetiology of diabetes mellitus in young adults: A prospective study from north India Sahoo Saroj Kumar, Zaidi Ghazala, Vipin Valam Puthussery, Chapla Aaron, Thomas Nihal, Yu Liping, Asthana Pranjul, Bhatia Eesh . Year : 2019 | Volume: 149 | Issue Number: 4 | Page: 479-488
4. Low prevalence of Islet Antibody negative type 1 diabetes mellitus among children and adolescents in north India. First author – under review for publication in Pediatric diabetes
5. John G, Asghari M, Vipin VP, Eapen V. (2019). Depression and Metabolic Syndrome: Two Sides of the Same Coin. J Biomed Sci Res1(2): 109
6. Technological Advances in the Treatment of Type 1 Diabetes – Book review, Vipin V P and Eesh Bhatia. November 2015. The National medical journal of India 28(2):103
7. “Best Practices and Tools for Titrating Basal Insulins: Expert Opinion from an Indian Panel via the Modified Delphi Consensus Method“. Sunil M Jain; K Seshadri; AG Unnikrishnan; M Chawla; P Kalra; VP Vipin; E Ravishankar; J Chordia; S Das; J Wazir; SM Bandookwala; N Deka; G Agarwal; VG Kumar; S Erande –Diabetes Ther

1. Insulin workshop – Starting insulin treatment in a patient with Type 2 Diabetes: Case based discussion – APICON 2019 Kochi
2. Application of newer technologies in the management of Diabetes mellitus – IMA state chapter – Pala 2018
3. Statin Induced diabetes – Hype or Fact? – RSSDI regional chapter – Thiruvalla 2018
4. Acute metabolic complications of Diabetes – Indian institute of Diabetes 2018, Trivandrum
5. Adrenal Fatigue, Maternal supplementation of Vitamin D and neonatal outcome – KENDOCON 2019

• Advisory board member for Novo Nordisk, Sanofi and Lupin diabetes division
• Give talks for Major Pharmaceutical companies like Novo Nordisk, Lilly, Novartis, MSD, Boehringer Ingelheim, Sanofi and Abott.